Carrera Bioscience Inc.

In September, Carrera Bioscience Inc. was selected to participate as a member of the 2018-2019 Cohort of the NIH SBIR/STTR Commercialization Accelerator Program (CAP) for Phase II awardee for the commercialization of the Loop-Mediated Isothermal Amplification (LAMP) Diagnostics for all of the hepatitis viruses – A, B, C, D and E.

Carrera attended the NIH CAP Commercialization Training Workshop in Los Angeles in October.

Our goal is to make this assay available worldwide!

WOW! 2018 has been a very busy year for Carrera Bioscience! We thought we should catch up on what has happened throughout the year before the new year starts!